NDC 66689-031-01 - Metoclopramide Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-031
- Requested NDC
- 66689-031-01
- Package NDCs from labels
- 66689-031-01, 66689-031-50
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2024-07-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoclopramide Hydrochloride - VistaPharm, LLC | VistaPharm, LLC | 2024-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66689-031-50 | 2024-01-30 | C162847 | 48780-1 | 1030e365-276c-111a-e063-dadaa90a10e2 | METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-031-01 | ML - Milliliter | 66689-031 | 21c6cdb2-83f7-412d-beb1-8dd49b4ba7f3 | 1 | 2013-02-13 |
| 66689-031-50 | ML - Milliliter | 66689-031 | 7ec00a6a-fe58-4173-80a2-fd83172446f1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Metoclopramide Hydrochloride | ACTIVE INGREDIENT | W1792A2RVD | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| Metoclopramide | ACTIVE MOIETY | L4YEB44I46 | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | METOCLOPRAMIDE HYDROCHLORIDE SOLUTION [VISTAPHARM INC.] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Atti amour Rose Anti-Aging Repair Classic Essence | NIACINAMIDE, GLYCERIN | RIVER SUNZ co.,Ltd | 1e874ac0-a993-be9e-e063-6394a90af424 | 2025-11-06 | Warnings | PDC6A3C0OX |
| Atti amour Rose Anti-Aging Repair Eye Cream | NIACINAMIDE, GLYCERIN | RIVER SUNZ co.,Ltd | 1eeb9c36-5bd8-ec90-e063-6294a90ae4e1 | 2025-11-06 | Warnings | PDC6A3C0OX |
| Atti amour Rose Anti-Aging Repair Serum | NIACINAMIDE, GLYCERIN | RIVER SUNZ co.,Ltd | 1eb08f86-eb2a-7f29-e063-6294a90a0516 | 2025-11-06 | Warnings | PDC6A3C0OX |
| Atti amour Rose Anti-Aging Repair Moisturizing Cream | NIACINAMIDE, GLYCERIN | RIVER SUNZ co.,Ltd | 1eec4cfe-d5a3-3570-e063-6294a90ac38b | 2025-11-06 | Warnings | PDC6A3C0OX |
| Metoclopramide | METOCLOPRAMIDE | Bryant Ranch Prepack | 84ec68c1-efa0-4ed2-9fae-d0cc17b0a6b4 | 2025-11-05 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Pranicura 5 | GLYCERIN, KAOLIN, CALAMINE, MENTHOL | Pranicura Products LLC | af520a58-3f3c-4d28-a41f-3ed8f74da095 | 2025-11-04 | Warnings | PDC6A3C0OX |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 506T60A25R |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2025-10-29 | Warnings | PDC6A3C0OX |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Publix Super Markets Inc | 354a640c-bc7e-45c8-9df0-8b5b01767f5c | 2025-10-29 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | PDC6A3C0OX |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.